In an immunohistochemical study of prostate carcinoma specimens, increased FOXC2 expression and EMT phenotypes were associated with castration resistance, metastasism and poor survival in PCa cases [158]. This evidence concerns the gene FOXC2 and posterior cortical atrophy.